Dr David Barzilai traced the development records of popular compounds and found many trace back to pharmaceutical companies.
Recap by typeshit. Post by Agingdoc🩺Dr David Barzilai🔔MD PhD MS MBA DipABLM on X.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
The telehealth company is also adding blood testing services alongside the lower costs for its compounded GLP-1 options.
Huberman says verified, US-made sourcing would change the peptide market, and wonders which compounds beyond GLPs would qualify.
A general explainer on why the body holds onto its large fat reserves even though they carry tens of thousands of calories.
Amy Maxmen reports on how experimental peptides are being hyped in optimization circles and where the talk goes wrong.
A personal story about the control he felt on the drug and the cravings for it that followed once he stopped.
Loading…